Mitchell Sokoloff to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Mitchell Sokoloff has written about Chemotherapy, Adjuvant.
Connection Strength
0.201
-
Sokoloff MH, Daneshmand S, Ryan CW. Current clinical trials in renal cell carcinoma. Urol Oncol. 2005 Jul-Aug; 23(4):289-92.
Score: 0.059
-
Katz EE, Suzue K, Wille MA, Krausz T, Rapp DE, Sokoloff MH. Primary malignant melanoma of the urethra. Urology. 2005 Feb; 65(2):389.
Score: 0.057
-
Sokoloff MH, Rinker-Schaeffer CW, Chung LW, Brendler CB. Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells. J Urol. 2004 Dec; 172(6 Pt 2):2539-44.
Score: 0.057
-
Jani AB, Sokoloff M, Shalhav A, Stadler W. Androgen ablation adjuvant to postprostatectomy radiotherapy: complication-adjusted number needed to treat analysis. Urology. 2004 Nov; 64(5):976-81.
Score: 0.014
-
Yang XJ, Sugimura J, Tretiakova MS, Furge K, Zagaja G, Sokoloff M, Pins M, Bergan R, Grignon DJ, Stadler WM, Vogelzang NJ, Teh BT. Gene expression profiling of renal medullary carcinoma: potential clinical relevance. Cancer. 2004 Mar 01; 100(5):976-85.
Score: 0.013